Bansisons Tea - Novyra Pharmachem Share Price

Bansisons Tea - Novyra Pharmachem Share Price

  • 11.34
BSE
  • Live
  • As On: 17 Jun, 2026, 04:01 PM IST
Loading...
Open-
High-
Low-
Prev Close-
Volume-
VWAP(₹)-

Key Metrics

PE Ratio(x)-1.34
EPS - TTM(₹)-8.46
MCap(₹ Cr.)7.18
MCap Rank-
PB Ratio(x)-
Div Yield(%)-
Face Value(₹)-
52W High(₹)16.55
52W Low(₹)3.01
MCap/Sales-
Beta(1 Month)-
BV/Share(₹)-

Bansisons Tea share price insights

  • Zero Debt Burden

    Company has no debt since last 5 years. (Source: Standalone Financials)
  • Employee & Interest Expense

    Company has spent less than 1% of its operating revenues towards interest expenses and 144.25% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • Bansisons Tea Share Price Update

    Share PriceValue
    Today/Current/Last11.34
    Previous Day11.93

Found Insights useful?

Bansisons Tea Share Price Returns

1 Day0.0%
1 MonthN.A.
3 MonthsN.A.
1 YearN.A.
3 YearsN.A.
5 YearsN.A.

Bansisons Tea Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income0.100.000.030.030.05
    Total Income Growth (%)--100.0010.33-37.37-
    Total Expenses5.440.010.030.040.10
    Total Expenses Growth (%)0.00-64.29-14.59-61.571,014.77
    EBIT-5.34-0.010.00-0.01-0.05
    EBIT Growth (%)--1,377.78---
    Profit after Tax (PAT)-5.34-0.010.00-0.01-0.05
    PAT Growth (%)--1,377.78---
    EBIT Margin (%)0.00-2.72-25.67-104.80
    Net Profit Margin (%)0.00-2.72-25.67-104.80
    Basic EPS (₹)-8.43-0.020.00-0.03-0.08
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue0.170.05-0.160.19
    Total Revenue Growth (%)248.96---17.30-6.71
    Total Expenses5.540.110.160.120.19
    Total Expenses Growth (%)4,865.32-29.9928.62-33.1468.32
    Profit after Tax (PAT)-5.37-0.06-0.160.010.00
    PAT Growth (%)---1,477.58241.87-95.71
    Operating Profit Margin (%)-5,147.310.000.0021.782.67
    Net Profit Margin (%)-5,147.310.000.007.712.25
    Basic EPS (₹)-0.85-0.10-0.260.010.01

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 144.25% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets1.496.146.126.246.22
    Total Assets Growth (%)-75.730.33-1.920.320.00
    Total Liabilities0.870.180.190.160.14
    Total Liabilities Growth (%)383.33-5.2618.7514.29-6.67
    Total Equity0.625.975.936.096.07
    Total Equity Growth (%)-89.610.67-2.630.330.00
    Current Ratio (x)0.861.672.516.664.36
    Total Debt to Equity (x)0.000.000.000.000.00
    Contingent Liabilities-----

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Zero Debt Burden

      Company has no debt since last 5 years. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities-3.79-0.19-0.140.14-0.06
    Net Cash used in Investing Activities3.850.08-0.010.03
    Net Cash flow from Financing Activities-0.150.25---
    Net Cash Flow-0.090.15-0.140.14-0.03
    Closing Cash & Cash Equivalent0.180.230.080.220.08
    Closing Cash & Cash Equivalent Growth (%)-24.08174.74-61.65188.85-28.29
    Total Debt/ CFO (x)0.000.000.000.000.00

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)-863.81-1.06-2.680.190.05
    Return on Capital Employed (%)-863.81-1.06-2.640.520.06
    Return on Assets (%)-360.94-1.03-2.600.180.05
    Interest Coverage Ratio (x)0.000.000.000.000.00
    Asset Turnover Ratio (x)0.03--0.020.02
    Price to Earnings (x)-1.76-59.17-13.00555.561,000.00
    Price to Book (x)15.240.620.350.990.48
    EV/EBITDA (x)-1.74-115.14-14.14112.11117.31
    EBITDA Margin (%)-5,119.630.000.0034.4316.01

    No Data Available

    Insights
    • Losing Shareholder's Money

      Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

Found Financials useful?

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters14,65,70023.15 %0.00
    Pledge00.00 %0.00
    Others48,64,30076.85 %0.00
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters23.1523.1523.1523.15
    Pledge0.000.000.000.00
    FII0.000.000.000.00
    DII0.000.000.000.00
    Mutual Funds0.000.000.000.00
    Others76.8576.8576.8576.85

Mutual Funds Ownership

No Data Available

Corporate Actions

  • General Meeting

    -

    Jun 02, 2026

    Board Meeting

    Reduction of Capital

    May 04, 2026

    Board Meeting

    Audited Results

    Apr 29, 2026

  • Announced onMeeting on
    May 04, 2026May 16, 2026
    Reduction of Capital
    Apr 29, 2026May 02, 2026
    Audited Results
    Apr 25, 2026Apr 29, 2026
    Audited Results
    Apr 25, 2026Apr 25, 2026
    Audited Results
    Apr 18, 2026Apr 18, 2026
    Audited Results
  • No Data Available

  • No Data Available

  • No Data Available

  • No Data Available

  • Announced onMeeting on
    Jun 02, 2026Jun 25, 2026
    -
    Nov 28, 2025Dec 31, 2025
    -
    Sep 09, 2025Sep 29, 2025
    -
    Feb 21, 2025Mar 26, 2025
    -
    Sep 20, 2024Sep 30, 2024
    A.G.M.

About Bansisons Tea

Novyra Pharmachem Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 7.18 Crore) operating in Tea / Coffee sector.

Show More

Industry

Tea / Coffee

Key Indices Listed On

-

Address

R S No 432, T P Scheme No 3, F P No 89/A,City Survey No 3763, Plot No C, Palky Plot No A,GroundFloor, Back Side, Pavthawala Compound,Surat, Gujarat - 395004

Executive Leadership

SA

Sandeep Agarwal

Whole Time Director
AA

Anilkumar Amreliya

Executive Director
CK

Chirag Kirtikumar Nanavati

Independent Director
HD

Hiren Dhirajlal Shah

Independent Director
Show More

Auditors

DGMS & Co.
Bijan Ghosh & Associates
R K Bihani & Associates
Agarwal & Sushil Kumar & Co.

FAQs about Bansisons Tea share

  • 1. What's Bansisons Tea share price today and what are Bansisons Tea share returns ?
    Bansisons Tea share price is Rs 11.34 as on 17 Jun, 2026, 04:01 PM IST. Bansisons Tea share price is remain unchanged by N.A. based on previous share price of Rs. 11.93.
  • 2. What is Bansisons Tea's 52 week high / low?
    52 Week high of Bansisons Tea share is Rs 16.55 while 52 week low is Rs 3.01
  • 3. What's the market capitalization of Bansisons Tea?
    Within the Tea / Coffee sector, Bansisons Tea stock has a market cap rank of -. Bansisons Tea has a market cap of Rs 7.18 Cr.
  • 4. What is the PE & PB ratio of Bansisons Tea?
    The PE ratio of Bansisons Tea stands at -1.34, while the PB ratio is 12.07.

Top Gainers

As on 09:54 AM | 19 Jun 2026
New India Assurance
191.00
12.34 (6.91%)
IFCI
87.16
4.85 (5.90%)
Carborundum Uni
1,258.00
65.80 (5.52%)
HFCL
209.61
9.99 (5.00%)
Berger Paints
526.40
21.35 (4.23%)

Top Losers

As on 09:54 AM | 19 Jun 2026
Infosys
1,039.70
-87.80 (-7.79%)
TCS
2,076.80
-126.50 (-5.75%)
Mphasis
2,204.60
-132.00 (-5.65%)
KPR Mill
1,128.45
-57.96 (-4.89%)
Tech Mahindra
1,377.10
-70.61 (-4.88%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.